日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cholinergic substrates of gait and postural impairments in Progressive Supranuclear Palsy

进行性核上性麻痹症步态和姿势障碍的胆碱能基础

Kanel, Prabesh; Carli, Giulia; Roytman, Stiven; van der Zee, Sygrid; Vangel, Robert; Barr, Jaimie; Brown, Taylor; Spears, C Chauncey; Narkis, Amanda; Slingerland, Sofie; Meles, Sanne; van Laar, Teus; Scott, Peter J H; Albin, Roger L; Bohnen, Nicolaas I

A multicenter longitudinal study of cholinergic subgroups in Parkinson disease

帕金森病胆碱能亚组的多中心纵向研究

Bohnen, Nicolaas I; Roytman, Stiven; van der Zee, Sygrid; Carli, Giulia; Michalakis, Fotini; Luker, Austin; Slingerland, Sofie; Frey, Kirk A; Scott, Peter J H; Koeppe, Robert A; van Laar, Teus; Albin, Roger L; Kanel, Prabesh

Modelling cholinergic and dopaminergic function over time in Parkinson's disease with and without GBA1 variants

对伴有和不伴有GBA1变异的帕金森病患者的胆碱能和多巴胺能功能随时间的变化进行建模

Slingerland, Sofie; de Meyer, Eline K R; van der Horn, Harm J; Carli, Giulia; Slomp, Anne C; d'Angremont, Emile; Boertien, Jeffrey M; Goethals, Ingeborg; Meles, Sanne K; van der Zee, Sygrid; van Laar, Teus

Cholinergic Degeneration and Cognitive Function in Early GBA1-Related Parkinson's Disease

早期GBA1相关帕金森病中的胆碱能变性和认知功能

Slingerland, Sofie; van der Zee, Sygrid; Carli, Giulia; Slomp, Anne C; d'Angremont, Emile; Boertien, Jeffrey M; van Laar, Teus

Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients

GBA相关新发帕金森病患者的胆碱能神经支配拓扑结构

Slingerland, Sofie; van der Zee, Sygrid; Carli, Giulia; Slomp, Anne C; Boertien, Jeffrey M; d'Angremont, Emile; Bohnen, Nicolaas I; Albin, Roger L; van Laar, Teus

Cholinergic deficiency in Parkinson's disease patients with visual hallucinations

帕金森病患者出现视觉幻觉时存在胆碱能缺乏

d'Angremont, Emile; van der Zee, Sygrid; Slingerland, Sofie; Slomp, Anne C; de Vries, Erik F J; van Laar, Teus; Sommer, Iris E

Reduced Thickness of the Retina in de novo Parkinson's Disease Shows A Distinct Pattern, Different from Glaucoma

新发帕金森病患者的视网膜厚度减少呈现出与青光眼不同的独特模式

Chrysou, Asterios; Heikka, Tuomas; van der Zee, Sygrid; Boertien, Jeffrey M; Jansonius, Nomdo M; van Laar, Teus

Fecal microbiome alterations in treatment-naive de novo Parkinson's disease

未经治疗的新发帕金森病患者的粪便微生物组改变

Boertien, Jeffrey M; Murtomäki, Kirsi; Pereira, Pedro A B; van der Zee, Sygrid; Mertsalmi, Tuomas H; Levo, Reeta; Nojonen, Tanja; Mäkinen, Elina; Jaakkola, Elina; Laine, Pia; Paulin, Lars; Pekkonen, Eero; Kaasinen, Valtteri; Auvinen, Petri; Scheperjans, Filip; van Laar, Teus

Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease

帕金森病中的胆碱能系统、注意力运动整合和认知控制

Albin, Roger L; van der Zee, Sygrid; van Laar, Teus; Sarter, Martin; Lustig, Cindy; Muller, Martijn L T M; Bohnen, Nicolaas I

S40. COMBINING PHARMACOTHERAPY OF BI 425809 WITH COMPUTERISED COGNITIVE TRAINING IN PATIENTS WITH SCHIZOPHRENIA: INITIAL EXPERIENCE OF A LARGE-SCALE MULTICENTRE RANDOMISED CLINICAL TRIAL

S40. 将BI 425809药物治疗与计算机化认知训练相结合治疗精神分裂症患者:一项大规模多中心随机临床试验的初步经验

d'Angremont, Emile; Renken, Remco; van der Zee, Sygrid; de Vries, Erik F J; van Laar, Teus; Sommer, Iris E C; Hake, Sanjay; Huang, Songqiao; McDonald, Sean; Pollentier, Stephane; Podhorna, Jana